Andrew Kim

President and CEO

5 past transactions

Flashback

Convertible Note in 2023
The soul of a film camera reborn in a digital era

Lumotive

Venture Round in 2023
Lumotive LLC specializes in developing advanced solid-state lidar systems utilizing liquid crystal metasurface (LCM) technology, primarily aimed at enhancing sensing and perception capabilities in autonomous vehicles and various other industries. Founded in 2017 and based in Bellevue, Washington, the company produces optical semiconductor solutions, including its proprietary Light Control Metasurface beam steering chips. These chips are designed for seamless integration into consumer electronics, robotics, and industrial automation, offering a compact and efficient means of delivering precise light control. Lumotive's innovative technology aims to simplify lidar systems by reducing their complexity, cost, and size while simultaneously improving performance and reliability, thereby facilitating mass adoption across multiple applications.

Vaxxas

Series C in 2022
Vaxxas is a biotechnology company based in Brisbane, Australia, focused on developing a novel needle-free vaccination technology. Established in 2011, Vaxxas employs proprietary dry-coating technology that significantly reduces or eliminates the need for refrigeration during the storage and transportation of vaccines, thereby addressing logistical challenges associated with the cold chain. The company's innovative delivery system features an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This method allows for the direct deposition of vaccines among a dense population of immune cells in the skin, potentially transforming the global delivery of vaccines.

LifeSignals

Series C in 2016
LifeSignals Group Inc. is a biotechnology company based in Fremont, California, that specializes in the development and manufacturing of system-on-a-chip biosensors and software for medical device manufacturers. Founded in 2006, the company focuses on creating wireless peripherals that enable effective patient health tracking by transmitting and receiving vital signals. Its product offerings include the Life Signal Patch, Life Signal Receiver, and a software development kit that supports sensor-based healthcare devices. Additionally, LifeSignals provides the Life Signal CardiacApp, which serves as a reference design for analyzing and displaying cardiac data from wearable patches. The company's innovative semiconductor platform is designed to capture and communicate vital signs from both humans and animals, facilitating the rapid development and commercialization of cost-effective, clinical-grade remote monitoring wearables.

Funetics

Seed Round in 2014
Funetics is a digital English-pronunciation platform based in Paddington, Australia, launched in July 2013. The company specializes in providing an English e-learning platform that focuses on teaching users proper pronunciation and fluency in the English language. Utilizing machine learning, Funetics analyzes the spoken language of its users to offer personalized recommendations and content tailored to individual learning profiles. This innovative approach enables users to improve their pronunciation skills and achieve fluency in English effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.